Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome (Q34018185)

30 July 2017

Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

30 July 2017

1 reference

1 reference

Martino Maria Zacchè

1

1 reference

30 July 2017

Luigi Caputo

2

1 reference

30 July 2017

Susanna Filippis

3

1 reference

30 July 2017

Gabrio Zacchè

4

1 reference

30 July 2017

Moreno Dindelli

5

1 reference

30 July 2017

Augusto Ferrari

6

1 reference

30 July 2017

1 August 2009

1 reference

Gynecological Endocrinology

30 July 2017

1 reference

30 July 2017

25

1 reference

30 July 2017

8

1 reference

30 July 2017

508-513

1 reference

Polycystic Ovary Syndrome

30 July 2017

1 reference

https://api.crossref.org/works/10.1080%2F09513590903015544

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590903015544

Consensus on infertility treatment related to polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590903015544

Insulin sensitizers for polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590903015544

Long-term metabolic, cardiovascular and neoplastic risks with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590903015544

Dermatology of androgen-related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590903015544

Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590903015544

Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590903015544

Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590903015544

Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590903015544

A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590903015544

Diet and nutrition in polycystic ovary syndrome (PCOS): pointers for nutritional management

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590903015544

Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590903015544

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590903015544

Second messengers of insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590903015544

chiro-inositol deficiency and insulin resistance: a comparison of the chiro-inositol- and the myo-inositol-containing insulin mediators isolated from urine, hemodialysate, and muscle of control and type II diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590903015544

Metformin therapy increases insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590903015544

Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590903015544

Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590903015544

Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590903015544

Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590903015544

Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590903015544

Treatment of hirsutism with myo-inositol: a prospective clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590903015544

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590903015544

Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590903015544

Clinical practice. Hair loss in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590903015544

Polycystic ovary syndrome and insulin-resistant hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590903015544

Glucose intolerance in polycystic ovary syndrome--a position statement of the Androgen Excess Society.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590903015544

Metformin for the treatment of the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590903015544

Metformin in polycystic ovary syndrome: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590903015544

Insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590903015544

Greek hyperinsulinemic women, with or without polycystic ovary syndrome, display altered inositols metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590903015544

10.1080/09513590903015544

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference